Anyway, the lack of any link between AHR expression and poor prognostic factors in our PTC series, together with the lack of any correlation with more de-differentiated histotypes from meta data analysis, prompt us to consider AHR as one of initial mediators of thyroid cancer development endorsed by BRAF, rather than a driver of the disease progression process. This evidence concerns the gene AHR and thyroid gland carcinoma.